Study of Cetuximab in Squamous Cell Carcinoma of the Skin Expressing EGFR

NCT00240682 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

37

Enrollment

OTHER

Sponsor class

Conditions

Skin Diseases
Carcinoma, Squamous Cell

Interventions

DRUG: cetuximab

Sponsor

Centre Hospitalier of Chartres

Collaborators

[object Object]